https://www.abbvie.co.jp/2026-11-050.5dailyhttps://www.abbvie.co.jp/who-we-are.html2026-05-170.5dailyhttps://www.abbvie.co.jp/who-we-are/our-principles.html2026-06-170.5dailyhttps://www.abbvie.co.jp/who-we-are/our-principles/equity-equality-inclusion-diversity.html2025-12-160.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity.html2024-12-030.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/protecting-human-rights-and-workplace-safety.html2026-09-270.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment.html2026-10-150.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2025.html2026-10-150.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2024.html2026-10-140.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2023.html2026-10-150.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2022.html2025-05-070.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2021.html2025-05-070.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/2020.html2025-05-070.5dailyhttps://www.abbvie.co.jp/who-we-are/operating-with-integrity/transparency-in-payment/allergan.html2025-05-070.5dailyhttps://www.abbvie.co.jp/who-we-are/message-from-the-president.html2026-04-280.5dailyhttps://www.abbvie.co.jp/who-we-are/our-vision.html2026-06-150.5dailyhttps://www.abbvie.co.jp/who-we-are/our-vision/beyond-the-best.html2026-05-280.5dailyhttps://www.abbvie.co.jp/who-we-are/company-overview.html2026-05-130.5dailyhttps://www.abbvie.co.jp/who-we-are/history-abbvie.html2026-05-130.5dailyhttps://www.abbvie.co.jp/who-we-are/awards-recognition.html2026-10-200.5dailyhttps://www.abbvie.co.jp/who-we-are/equity-equality-inclusion-diversity.html2025-12-220.5dailyhttps://www.abbvie.co.jp/science.html2026-05-120.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus.html2026-05-250.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus/immunology.html2026-02-200.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus/viral_infectious_disease.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus/neuroscience.html2026-05-180.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus/oncology.html2025-12-170.5dailyhttps://www.abbvie.co.jp/science/areas-of-focus/aesthetics.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/pipeline.html2026-11-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials.html2025-02-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results.html2026-10-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m22-000.html2025-10-270.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m19-977.html2025-10-270.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/3101-306-002.html2025-10-270.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m23-515.html2025-10-270.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m17-377.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m14-234.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m20-040.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m14-663.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m14-431.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m14-433.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-098.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-813.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-833.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-988.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-006.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-123.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/3101-303-002.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m13-545.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m19-130.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m18-816.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-741.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m14-031.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-067.html2024-07-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-555.html2024-07-120.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m20-370.html2024-10-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m19-135.html2024-10-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m19-051.html2024-10-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m20-466.html2024-10-290.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m23-696.html2025-02-200.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m20-186.html2025-02-200.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-997.html2025-02-200.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m13-694.html2025-02-200.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m22-509.html2026-03-180.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-554.html2026-03-180.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m15-572.html2026-03-180.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-045.html2026-07-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m22-056.html2026-07-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-191.html2026-07-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m20-075.html2026-07-150.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m16-043.html2026-09-240.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m22-080.html2026-09-240.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-results/m24-008.html2026-09-240.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-detail.html2024-09-200.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list.html2026-11-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology02.html2025-08-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology01.html2025-08-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology03.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology04.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology05.html2026-05-270.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology06.html2025-05-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology07.html2026-08-120.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology08.html2026-11-090.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology09.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology10.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology01.html2026-05-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology02.html2026-11-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology03.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology04.html2025-09-010.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology05.html2026-04-030.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology06.html2026-04-020.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology07.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology08.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology09.html2025-10-010.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology10.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience01.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience02.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience03.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience05.html2025-08-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience06.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience07.html2025-09-010.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/eye-care02.html2026-08-120.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/hiv.html2025-11-050.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/medical-aesthetic.html2026-08-120.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/eye-care01.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology11.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology12.html2026-08-120.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/neuroscience08.html2025-04-070.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology13.html2025-08-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology14.html2025-08-080.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology15.html2026-03-040.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology16.html2026-08-170.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/immunology11.html2026-10-160.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-list/oncology17.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/authentication.html2026-04-030.5dailyhttps://www.abbvie.co.jp/science/clinical-trials/clinical-trials-info.html2026-08-310.5dailyhttps://www.abbvie.co.jp/science/activity.html2025-06-050.5dailyhttps://www.abbvie.co.jp/science/activity/abbvie-subsidy.html2026-03-150.5dailyhttps://www.abbvie.co.jp/science/activity/shichikawa-abbvie.html2026-05-210.5dailyhttps://www.abbvie.co.jp/science/activity/mdsj.html2025-12-030.5dailyhttps://www.abbvie.co.jp/science/areas-of-innovation.html2026-08-160.5dailyhttps://www.abbvie.co.jp/science/areas-of-innovation/areas-of-innovation.html2026-08-120.5dailyhttps://www.abbvie.co.jp/science/partner-with-us.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/partner-with-us/innovationaward.html2026-10-130.5dailyhttps://www.abbvie.co.jp/science/partner-with-us/innovationaward/2025.html2026-06-170.5dailyhttps://www.abbvie.co.jp/science/partner-with-us/partnering-campaign.html2026-07-300.5dailyhttps://www.abbvie.co.jp/science/partner-with-us/partnering-campaign/campaign-details.html2026-07-290.5dailyhttps://www.abbvie.co.jp/patients.html2026-05-200.5dailyhttps://www.abbvie.co.jp/patients/immunology.html2026-01-120.5dailyhttps://www.abbvie.co.jp/patients/immunology/ibd.html2024-07-090.5dailyhttps://www.abbvie.co.jp/patients/oncology.html2026-01-070.5dailyhttps://www.abbvie.co.jp/patients/psycho_neurologic_disease.html2026-05-190.5dailyhttps://www.abbvie.co.jp/patients/psycho_neurologic_disease/parkinson.html2026-05-180.5dailyhttps://www.abbvie.co.jp/patients/psycho_neurologic_disease/migraine.html2026-05-190.5dailyhttps://www.abbvie.co.jp/patients/efforts-to-eliminate-hepatitis-c.html2026-05-290.5dailyhttps://www.abbvie.co.jp/patients/disease-information-site.html2026-06-230.5dailyhttps://www.abbvie.co.jp/patients/voice-of-patients.html2026-09-100.5dailyhttps://www.abbvie.co.jp/patients/products.html2026-05-130.5dailyhttps://www.abbvie.co.jp/patients/product-quality-and-safety.html2024-07-090.5dailyhttps://www.abbvie.co.jp/patients/efforts-to-eradicate-hepatitis-c.html2024-08-040.5dailyhttps://www.abbvie.co.jp/join-us.html2026-08-260.5dailyhttps://www.abbvie.co.jp/join-us/message-from-head-of-hr.html2025-06-260.5dailyhttps://www.abbvie.co.jp/join-us/message01.html2026-08-260.5dailyhttps://www.abbvie.co.jp/join-us/opportunities.html2026-11-080.5dailyhttps://www.abbvie.co.jp/join-us/opportunities/seminar.html2026-10-070.5dailyhttps://www.abbvie.co.jp/join-us/opportunities/challenged.html2026-07-220.5dailyhttps://www.abbvie.co.jp/join-us/opportunities/challenged/employment-situation.html2026-01-070.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie.html2025-04-300.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/learning-and-development.html2025-07-140.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/well-being-in-the-workplace.html2026-06-240.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/employee-resource-groups.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/employee-resource-groups/gender.html2026-03-180.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/employee-resource-groups/generations.html2026-03-050.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/employee-resource-groups/abbvie-pride.html2026-06-250.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/employee-resource-groups/ability-at-abbvie.html2026-07-090.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/benefits.html2025-04-210.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees.html2026-08-210.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice22.html2026-05-120.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice21.html2026-03-260.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice20.html2026-03-260.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice19.html2026-03-260.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice18.html2026-03-080.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice17.html2026-03-080.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice16.html2026-03-080.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice14.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice11.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice10.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice8.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice7.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice6.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice5.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice3.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/life-at-abbvie/voice-of-employees/voice2.html2025-12-160.5dailyhttps://www.abbvie.co.jp/join-us/why-abbvie.html2024-07-090.5dailyhttps://www.abbvie.co.jp/join-us/myjourneymychoice.html2026-04-010.5dailyhttps://www.abbvie.co.jp/join-us/key-facts.html2026-11-100.5dailyhttps://www.abbvie.co.jp/sustainability.html2026-09-100.5dailyhttps://www.abbvie.co.jp/sustainability/environmental-social-and-governance.html2026-05-130.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy.html2026-07-130.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/employee-engagement.html2026-07-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/other-activities.html2026-07-130.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241103.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241116.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241107.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241012.html2026-09-100.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241001.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20241003.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240803.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240808.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240624.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240625.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240620.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240627.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240626.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240614.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240518.html2024-07-250.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/connection-with-society/20240527.html2025-12-220.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/other-activities2025.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/other-activities2024.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/other-activities2023.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/other-activities2022.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/other-activities2019.html2026-04-140.5dailyhttps://www.abbvie.co.jp/sustainability/philanthropy/archive/covid-19_nitiatives.html2024-07-090.5dailyhttps://www.abbvie.co.jp/sustainability/sdgs-action.html2026-07-010.5dailyhttps://www.abbvie.co.jp/sustainability/health-management.html2026-10-260.5dailyhttps://www.abbvie.co.jp/sustainability/multistakeholders.html2026-09-140.5dailyhttps://www.abbvie.co.jp/press-release.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-announces-chmp-positive-opinion-for-glecaprevir-hydrate-pibrentasvir-as-a-treatment-for-patients-with-acute-hepatitis-c-virus-infection1.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-to-present-data-on-previously-untreated-chronic-lymphocytic-leukemia-at-the-2026-european-hematology-association-congress.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvies-atgepant-is-being-developed-in-europe-as-an-acute-treatment-for-adult-migraine-patients.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvies-venetoclax-additional-combination-therapy-for-previously-untreated-chronic-lymphocytic-leukemia.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvies-bispecific-antibody-etentamig-recombinant-designated-under-the-sakigake-designation-system.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-japan-innovation-award-call-for-applications-launched-in-partnership-with-biolabs.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-files-for-approval-of-additional-indication-for-upadacitinib-in-japan-for-the-treatment-of-takayasu-arteritis.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-submits-application-for-partial-approval-change-for-subcutaneous-induction-therapy-with-risankizumab-in-adult-patients-with-moderately-to-severely-active-crohns-disease.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-presents-new-data-demonstrating-broad-progress-across-its-next-generation-oncology-pipeline-at-the-2026-asco-annual-meeting.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-presents-new-long-term-data-elevating-the-standard-of-care-for-inflammatory-bowel-disease-tbd-at-digestive-disease-week-2026.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-submits-fda-application-for-upadacitinib-as-a-treatment-for-adults-and-adolescents-with-severe-alopecia-areata.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-submits-fda-approval-application-for-risankizumab-subcutaneous-induction-therapy-in-adult-patients-with-moderately-to-severely-active-crohns-disease.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/allergan-aesthetics-files-for-manufacturing-and-marketing-approval-in-japan-to-expand-indication-for-botulinum-toxin-type-a-product-to-include-forehead-expression-lines.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-announces-first-quarter-2026-results.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-presents-new-clinical-trial-and-real-world-evidence-aimed-at-advancing-the-standard-of-care-for-immune-mediated-skin-diseases-at-the-aad-annual-meeting.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-and-biolabs-enter-into-strategic-partnership.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-launches-oral-medication-aquipta-atogepant-in-jjapan-for-the-prevention-of-migraine-attacks.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/notice-of-personnel-changes.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvies-venclexta-venetoclax-u-s-fda-approval-for-combination-therapy-with-acalabrutinib-for-previously-untreated-chronic-lymphocytic-leukemia.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-obtains-orphan-drug-designation-in-japan-for-upadacitinib-for-takayasu-arteritis-refractory-to-existing-therapies.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvles-for-approval-in-japan-to-add-an-indication-for-upadacitinib-as-a-treatment-for-vitiligo.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-submits-applications-to-fda-and-ema-for-approval-of-upadacitinib-for-the-treatment-of-adult-and-adolescent-patients-with-non-segmental-vitiligo.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/allergan-aesthetics-launches-skinvive-by-juvederm-vista-in-japan-a-hyaluronic-acid-product-that-improves-skin-quality.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-obtains-manufacturing-and-marketing-approval-in-japan-for-aquipta-atogepant-for-the-prevention-of-migraine-attacks.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbVie-announces-fourth-quarter-and-full-year-2025-results.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-ranked-14th-in-the-large-sized-company-category-of-the-2026-best-workplaces-in-japan-list.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-introduces-area-partnera-new-work-system-without-relocation.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-receives-european-commission-approval-for-glecaprevir-hydrate-pibrentasvir-as-treatment-for-patients-with-acute-hepatitis-c.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-announces-second-quarter-2026-results.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-receives-european-commission-approval-for-epcoritamab-in-combination-with-lenalidomide-and-rituximab-for-the-treatment-of-relapsed-or-refractory-follicular-lymphoma.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/positive-top-line-results-announced-from-the-phase-3-affirm-trial-evaluating-induction-therapy-with-subcutaneous-skyrizi-risankizumab-in-patients-with-crohns-disease.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-ranked-9th-in-the-large-company-category-of-the-2026-best-workplaces-for-women-ranking-in-japan.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/risankizumab-receives-us-fda-approval-as-a-treatment-for-pediatric-patients-with-psoriatic-disease.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-receives-european-commission-approval-for-risankizumab-as-a-treatment-for-pediatric-patients-with-moderate-to-severe-plaque-psoriasis.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-files-for-approval-in-japan-to-expand-indication-for-glecaprevir-hydrate-pibrentasvir-to-include-treatment-of-acute-hepatitis-c.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-reports-positive-results-from-a-phase-3trial-of-epcolitamab-and-lenalidomide-combination-therapy-in-patients-with-relapsed-or-refractory-diffuse-large-B-cell-lymphoma.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-to-present-new-data-in-its-hematologic-oncology-portfolio-at-the-2026-european-hematology-association-eha-congress.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/call-for-entries-opens-for-the-6th-abbVie-art-project-perspectives.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-japan-business-results-2025.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-announces-european-commission-approval-of-rinvoq-r-upadacitinib-for-the-treatment-of-adults-and-adolescents-with-non-segmental-vitiligo.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/abbvie-announces-european-commission-approval-of-rinvoq-r-upadacitinib-for-the-treatment-of-adults-and-adolescents-with-severe-alopecia-areata.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/rinvoq-upadacitinib-jia-approval-japan.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/botox-vista-masseter-hypertrophy-japan-approval.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/notice-of-personnel-changes0.html2026-09-010.5dailyhttps://www.abbvie.co.jp/press-release/2026-news-archive.html2026-11-030.5dailyhttps://www.abbvie.co.jp/press-release/2025-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2024-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2023-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2022-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2021-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2020-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2019-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2018-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2017-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2016-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2015-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2014-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2013-news-archive.html2026-09-020.5dailyhttps://www.abbvie.co.jp/press-release/2026-09-07-publication-vitiligo-treatment-japan-journal-of-dermatology.html2026-09-030.5dailyhttps://www.abbvie.co.jp/press-release/2026-09-29-abbvie-upadacitinib-hs-orphan-drug-japan.html2026-09-280.5dailyhttps://www.abbvie.co.jp/press-release/2026-09-16-skyrizi-pediatric-psoriasis-approval.html2026-09-140.5dailyhttps://www.abbvie.co.jp/press-release/2026-09-16-epkinly-fl-r2-combination-approval.html2026-09-150.5dailyhttps://www.abbvie.co.jp/press-release/2026-09-28-abbvie-cervino-myeloma-topline-data.html2026-09-240.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-01-atogepant-menstrual-migraine-phase3-results.html2026-09-300.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-06-abbvie-japan-innovation-award-winners.html2026-10-050.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-06-abbvie-skyrizi-crohns-sc-ema-submission.html2026-10-050.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-13-abbvie-xen45-glaucoma-japan-approval.html2026-10-120.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-20-epcoritamab-rchop-dlbcl-pfs-results.html2026-10-190.5dailyhttps://www.abbvie.co.jp/press-release/2026-10-23-rinvoq-oral-solution-jia-japan-launch.html2026-10-210.5dailyhttps://www.abbvie.co.jp/press-release/2026-11-05-abbvie-q3-2026-earnings-results.html2026-11-030.5dailyhttps://www.abbvie.co.jp/info.html2026-11-030.5dailyhttps://www.abbvie.co.jp/info/2026_1104.html2026-11-060.5dailyhttps://www.abbvie.co.jp/info/2026_1020.html2026-11-060.5dailyhttps://www.abbvie.co.jp/info/2026_0928.html2026-09-240.5dailyhttps://www.abbvie.co.jp/info/2026_0924.html2026-09-230.5dailyhttps://www.abbvie.co.jp/info/2026_0310.html2026-10-190.5dailyhttps://www.abbvie.co.jp/info/2026_0309.html2026-03-080.5dailyhttps://www.abbvie.co.jp/info/2025_0925.html2025-09-250.5dailyhttps://www.abbvie.co.jp/info/2025_0630.html2025-07-020.5dailyhttps://www.abbvie.co.jp/info/2025_0310.html2025-03-100.5dailyhttps://www.abbvie.co.jp/info/2024_1101.html2024-10-310.5dailyhttps://www.abbvie.co.jp/info/2024_0919.html2024-10-200.5dailyhttps://www.abbvie.co.jp/info/2024_0814.html2024-08-130.5dailyhttps://www.abbvie.co.jp/info/2024_0513.html2024-07-100.5dailyhttps://www.abbvie.co.jp/info/2024_0318.html2024-07-100.5dailyhttps://www.abbvie.co.jp/info/2024_0311.html2024-07-110.5dailyhttps://www.abbvie.co.jp/info/2023_1002.html2024-07-100.5dailyhttps://www.abbvie.co.jp/info/2023_0308.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup.html2025-12-180.5dailyhttps://www.abbvie.co.jp/pickup/artproject.html2026-06-150.5dailyhttps://www.abbvie.co.jp/pickup/artproject/06.html2026-07-050.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05.html2025-07-230.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/gallery.html2025-12-010.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/picture.html2025-07-240.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/craftandothers.html2025-07-240.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/others.html2025-07-240.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/comment.html2025-08-030.5dailyhttps://www.abbvie.co.jp/pickup/artproject/05/exhibition.html2025-12-010.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04.html2025-02-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/comment.html2024-07-120.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/gallery.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/picture.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/craftandothers.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/caligrapherandphoto.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/04/sculptureandothers.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03/comment.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03/gallery.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03/picture.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03/craftandothers.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/03/caligrapherandphoto.html2024-12-240.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/comment.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/gallery.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/picture.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/crafts.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/others.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/photo.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/02/application.html2024-07-110.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01/comment.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01/picture.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01/crafts.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01/others.html2026-01-080.5dailyhttps://www.abbvie.co.jp/pickup/artproject/01/photo.html2026-01-080.5dailyhttps://www.abbvie.co.jp/a-connect.html2024-07-090.5dailyhttps://www.abbvie.co.jp/contactus.html2025-11-110.5yearlyhttps://www.abbvie.co.jp/site-map.html2026-09-230.5dailyhttps://www.abbvie.co.jp/privacy.html2025-05-280.5dailyhttps://www.abbvie.co.jp/terms-of-use.html2024-12-020.5dailyhttps://www.abbvie.co.jp/search-results.html2025-01-280.5dailyhttps://www.abbvie.co.jp/example.html2024-06-100.5dailyhttps://www.abbvie.co.jp/termsofuse.html2024-07-090.5dailyhttps://www.abbvie.co.jp/terms.html2025-10-220.5dailyhttps://www.abbvie.co.jp/social-media-community-guidelines.html2026-09-270.5daily